Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis
Phase of Trial: Phase III
Latest Information Update: 13 Jul 2018
Price : $35 *
At a glance
- Drugs Efinaconazole (Primary)
- Indications Onychomycosis
- Focus Registrational; Therapeutic Use
- Sponsors Dow Pharmaceutical Sciences
- 13 Jul 2018 According to a Bausch Health Companies media release, Valeant Pharmaceuticals International changed its name to Bausch Health Companies.
- 01 Apr 2017 Results of post-hoc pooled analysis comparing data for Latino (n=270) versus non-Latino populations (n=1380) of the two pivotal studies (NCT01007708 and NCT01008033), published in the Cutis Journal.
- 05 Jun 2014 New trial record